Drug profile · INN
fluphenazine enanthate
PROLIXIN ENANTHATE
fluphenazine enanthate (PROLIXIN ENANTHATE) is a dopamine d2 receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — fluphenazine enanthate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
fluphenazine enanthate (PROLIXIN ENANTHATE) is a dopamine d2 receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine D2 receptor antagonist
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is fluphenazine enanthate?
fluphenazine enanthate (PROLIXIN ENANTHATE) is a dopamine d2 receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for fluphenazine enanthate?
PROLIXIN ENANTHATE is a marketed brand name for fluphenazine enanthate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fluphenazine enanthate?
fluphenazine enanthate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.